Your comments about Nader and most longs’ opinion of him are spot-on.
Great CEO? No way.
Greatest in the short term for this fledgling biotech, until 1st approval or acquisition? Absolutely.
Replacing the c-suite RIGHT NOW would be madness.
(8)
(1)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-